Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial.
Bryant RJ. et al, (2025), Lancet Oncol, 26, 583 - 595
Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of epithelial cancers.
Erickson A. et al, (2025), PLoS One, 20
Integrating multiparametric MRI with spatial transcriptomics to identify "Radio-Spatial Genomic" features of prostate cancer using artificial intelligence
Anbarasan T. et al, (2025), CANCER RESEARCH, 85
Mapping clonal heterogeneity and stromal dynamics in prostate cancer
Figiel S. et al, (2025), CANCER RESEARCH, 85
Stress-Induced Rab11a-Exosomes Induce Amphiregulin-Mediated Cetuximab Resistance in Colorectal Cancer (vol 13, e12465, 2024)
Mason JD. et al, (2025), JOURNAL OF EXTRACELLULAR VESICLES, 14
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer.
Srinivasan S. et al, (2024), Nat Commun, 15
A Comprehensive National Survey of Prostate-specific Antigen Testing and Prostate Cancer Management in France: Uncovering Regional and Temporal Disparities.
Cussenot O. et al, (2024), Eur Urol Oncol, 7, 978 - 981
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel.
Berrens A-C. et al, (2024), Eur J Nucl Med Mol Imaging, 51, 2893 - 2902
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy.
Hamdy FC. et al, (2024), Eur J Nucl Med Mol Imaging, 51, 3009 - 3025
Re: Annika Herlemann, Janet E. Cowan, Samuel L. Washington 3rd, et al. Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. Eur Urol. 2024;85:565-573.
Cussenot O. et al, (2024), Eur Urol, 86, e48 - e49
Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease.
Charlton PV. et al, (2024), Prostate, 84, 977 - 990
Screening and active surveillance in prostate cancer: the dilemma continues.
Hamdy FC. et al, (2024), BJU Int, 134, 1 - 2
Stress-induced Rab11a-exosomes induce amphiregulin-mediated cetuximab resistance in colorectal cancer.
Mason JD. et al, (2024), J Extracell Vesicles, 13
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
Martin RM. et al, (2024), JAMA, 331, 1460 - 1470
Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547-58.
Hamdy FC. and Donovan JL., (2024), Eur Urol, 85, e41 - e42
Reply to Greg Shaw, John D. Kelly, and Monique J. Roobol's Letter to the Editor re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023;388:1547-58.
Hamdy FC. and Donovan JL., (2024), Eur Urol, 85, e54 - e55